Skip to content
drillr.ai
Sign up

301207.SZ

华兰疫苗

SZSE · Healthcare · C 制造业 · CN

CNY 17.08
−4.31%
Ask drillr

  • Aug 28, 2026, 08:56 UTC

    Hualan Biological Vaccine Inc. proposed a cash dividend of 1 yuan per 10 shares (tax included) based on a base of 595 million shares, with no bonus shares and no capital reserve conversion.

    Source:

  • Aug 28, 2026, 08:56 UTC

    Hualan Biological Vaccine Inc. announced its first-half 2026 results: net profit attributable to shareholders was 36.4432 million yuan, up 75.23% year-on-year, with revenue of 44.3853 million yuan, down 25.98%.

    Source:

  • Aug 10, 2026, 07:34 UTC

    Hualan Biological's controlling subsidiary Hualan Vaccine is conducting research and development of a novel influenza virus mRNA vaccine.

    Source: